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Background: How to properly manage clinically negative neck of head and neck cancer patients is a controversial
topic. Research is now directed toward finding a method sensitive enough to bring the risk of occult metastases
below 20%. The aim of this review was to compare the diagnostic accuracy of different imaging modalities,
including CT, MRI, PET and US, in clinically N0 head and neck cancer patients.
Methods: For this systematic review and meta-analysis, PubMed and the Cochrane Database were searched for
relevant original articles published up to May 2011. Inclusion criteria were as follows: articles were reported in
English; CT, MRI, PET or US were performed to identify cervical metastases in clinically N0 head and neck squamous
cell carcinoma; and data were sufficient for the calculation of true-positive or false-negative values. A bivariate
random effect model was used to obtain pooled sensitivity and specificity. The positive and negative test
probability of neck metastasis was generated based on Bayesian theory and collected data for different pre-test
possibilities.
Results: Of the 168 identified relevant articles, 7 studies fulfilled all inclusion criteria for CT, 6 studies for MRI, 11
studies for PET and 8 studies for US. There was no difference in sensitivity and specificity among these imaging
modalities, except CT was superior to US in specificity. The pooled estimates for sensitivity were 52% (95%
confidence interval [CI], 39%~ 65%), 65% (34 ~ 87%) 66% (47 ~ 80%), and 66% (45 ~ 77%), on a per-neck basis for CT,
MRI, PET and US, respectively. The pooled estimates for specificity were 93% (87%~ 97%), 81% (64 ~ 91%), 87%
(77 ~ 93%), and 78% (71 ~ 83%) for CT, MRI, PET and US, respectively. With pre-examination nodal metastasis
probabilities set at 10%, 20% and 30%, the post-exam probabilities of positive nodal metastasis rates were 47%, 66%
and 77% for CT; 27%, 46% and 59% for MRI; 36%, 56% and 69% for PET; and 25%, 42% and 56% for US, respectively.
Negative nodal metastasis probabilities were 95%, 89% and 82% for CT; 95%, 90% and 84% for MRI; 96%, 91% and
86% for PET; and 95%, 90% and 84% for US, respectively.
Conclusions: Modern imaging modalities offer similar diagnostic accuracy to define and diagnose clinically N0
neck. Minimizing morbidity and avoiding elective neck dissection is acceptable in some select cases.* Correspondence: mslai@ntu.edu.tw
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Lymph node status is one of the most important pre-
dictors of poor prognosis in head and neck cancers.
For patients with clinically positive (cN+) neck lymph
node metastasis, modified radical neck dissection is a
standard procedure. For patients with clinically nega-
tive (cN0) neck, there are two major management
strategies, which include elective neck dissection or a
“watchful waiting policy”. Cervical lymph node metas-
tasis staged by palpation has been demonstrated to be
inaccurate; the rate of occult cervical nodal metastases
is at least 30% by simple palpation [1]. To avoid the
unnecessary treatment of histologically negative necks,
a staging technique must be sensitive enough to re-
duce the risk of occult metastases to less than 20%,
which means a negative predictive value (NPV) of
more than 80% [2,3]. Bayesian logic states that the
probability of a disease being present given that a test
is negative depends on the pre-test probability or the
prevalence of the disease, and the sensitivity and spe-
cificity of the test can be described by the following
formula [4]:
Negative predictive value
¼ specificity  1 prevalenceð Þ
= specificity  1 prevalenceð½
þ 1 sensitivityð Þ  prevalence
With the development of modern imaging modalities,
the American Joint Committee on Cancer has stated that
clinical staging should include physical examination as
well as the results of other imaging modalities. Research
is now directed toward finding a staging method sensi-
tive enough to bring the risk of occult metastases below
20%. Previous meta-analyses [2,5] compared the diagnos-
tic accuracy of different imaging modalities in neck node
evaluation. However, these studies looked at a mixture of
cN+ and cN0 patients, and no study has focused only on
patients with cN0 necks. The aim of this study was to
complete a systematic review for the performance of dif-
ferent imaging modalities, i.e., computed tomography
(CT), magnetic resonance imaging (MRI), positron emis-
sion tomography (PET) and ultrasound (US), in the
evaluation of neck lymph node metastasis in clinically
N0 head and neck cancer patients.
Methods
Literature search
A computerized systematic literature search was per-
formed by one reviewer (Liao LJ). Abstracts were
selected for English articles reporting on diagnostic per-
formance in the detection of lymph node metastasis in
head and neck cancers. The search strategy used text
and relevant indexing to capture the concept ofultrasonography in head and neck cancer patients with
N0 neck evaluations.
PubMed (up to May 2011) and CENTRAL (via the
Cochrane database up to October 2010) were searched
using the following keywords: (a) (Head and Neck Neo-
plasms[MH]) NOT (Thyroid Neoplasms[MH] OR
Esophageal Neoplasms[MH] OR Nasopharyngeal Neo-
plasms[MH] OR Salivary Gland Neoplasms[MH] OR
Melanoma[MH] OR Parathyroid Neoplasms[MH]); (b)
Diagnostic imaging[MH]; (c) lymph node[TW] OR neck
node[TW]; and (d) sensitivity[TW] OR accuracy[TW].
Human studies with abstracts in English were included.
Reviews, letters to the author, comments and case
reports were excluded.
From the selected abstracts, two reviewers (Lo WC
and Wang CT) separately screened the full text of these
potentially eligible articles in which computed tomog-
raphy (CT), magnetic resonance imaging (MRI), positron
emission tomography (PET) and ultrasound (US) were
utilized. Reference lists were manually screened for add-
itional relevant articles.
Inclusion criteria
There were two major study groups according to the
clinical node staging of the patient population in each
study. The first group included studies of patients who
had pathologically positive head and neck cancer and
clinically negative cervical lymph nodes (cN0) before the
imaging examination. The second group included studies
with mixed patient populations (head and neck malig-
nancy with both cN0 and cN+). We included studies
with individual patient data available for cN0.
Based on the full text reports, studies were selected if
they fulfilled all of the following inclusion criteria: (a)
histopathology findings for neck dissection (specimens
obtained at surgery) or sufficient follow-up time were
used as the reference standard; (b) the primary tumor
and lymph node metastases were squamous cell carcin-
omas (SCCs); and (c) sufficient data were presented to
construct a 2 × 2 contingency table (sensitivity and/or
specificity with absolute numbers of false positive (FP),
false negative (FN), true positive (TP) and true negative
(TN) findings) for the imaging modalities compared
using the reference standard.
Exclusion criteria
Studies were excluded if raw data were not presented.
We also excluded studies with both cN0 and cN positive
patients, where individual data for cN0 patients were not
available.
Quality assessment of primary studies
The Quality Assessment of Diagnostic Accuracy Studies
(QUADAS)[6] quality assessment tool was used to
Figure 1 Flow chart of the study selection process. Of the 168 identified relevant articles, 7 studies fulfilled all inclusion criteria for CT, 6
studies for MRI, 11 studies for PET and 8 studies for US.
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study. This tool and the definitions of the characteristics
have previously been fully described [6]. We assigned a
design characteristic with a score of 1 if the evaluation
criteria were met or 0 if the design characteristic was not
preset or was unclear. Each study that met the inclusion
criteria was analyzed by two independent reviewers
(Wang CT and Lo WC). When there was a discrepancy
between the reviewers, a consensus reviewer (Liao LJ)
resolved these differences. Difference in the QUADAS
score among different modalities was tested using the
Kruskal-Wallis test.
Data analysis/synthesis
The primary outcome for analysis was the diagnostic
performance of imaging examinations that detected the
neck lymph node metastasis compared with the refer-
ence standard of neck dissection specimens. Sensitivities
and specificities with a 95% confidence interval (CI)
values were reported for individual studies. Pooled sensi-
tivities and specificities of CT, MRI, PET and US in neck
lymph node metastasis of cN0 neck from individual
studies were calculated using a bivariate random effect
model [7]. The random effect model incorporated the
heterogeneity of the studies into the analysis of the over-
all efficacy. The differences in sensitivities and specifici-
ties were tested using a bivariate random effect model.
Likelihood ratios are metrics that are calculated using a
combination of sensitivity and specificity values. The
positive likelihood ratio (LR+) is defined as the ratio of
sensitivity (1-specificity), whereas the negative likelihood
ratio (LR-) is defined as the ratio of specificity (1-sensitivity). When a diagnostic test has absolutely no dis-
criminating ability, both likelihood ratios equal 1. The
performance of each diagnostic modality was shown
using summary receiver operating characteristic (ROC)
curves. The positive and negative post-test probability
was generated based on Bayesian theory, and collected
data were tabulated for 10%, 20% and 30% pre-test prob-
abilities of cN0 neck. Statistical analyses were completed
using STATA version 10.0 (Stata Corp.).
Results
The abstracts and titles of 168 primary studies were
identified for initial review based on the described
search strategy. Full-text reviews were required for 65
publications to determine study eligibility. Subse-
quently, a total of 21 articles were selected based on
agreement between the two reviewers. During the
search process (Figure 1), we found that most studies
were excluded due to a mix of cN0 and cN+patients
without individual patient data for 2 × 2 tables. Seven
studies fulfilled all inclusion criteria for CT, 6 studies
for MRI, 11 studies for PET and 8 studies for US. The
sensitivities and specificities with 95% confidence inter-
val (CI) values and QUDAS scores for individual stud-
ies are summarized in Table 1.
There was no difference in the pooled sensitivity
among these imaging modalities. The pooled estimates
(Table 2 and Figure 2) for sensitivity were 52% (95% con-
fidence interval [CI], 39%~65%), 65% (34 ~ 87%), 66%
(47~ 80%) and 66% (54~ 77%) on a per-neck basis for
CT, MRI, PET and US, respectively. CT was superior to
US in specificity, but there was no difference among CT,
Table 1 Summary of the included studies





Stevens MH 1985 Arch Otolaryngol Head Neck Surg CT 5 1 1 9 83%(54-100%) 90%(71-100%) 9
Maremonti P 1997 J Craniomaxillofac Surg CT 6 0 6 12 50%(22-78%) 100% 7
Righi PD 1997 Head Neck CT 6 0 4 23 60%(30-90%) 100% 7
Byers RM 1998 Head Neck CT 2 2 9 12 18%(0-41%) 86%(67-100%) 5
Myers LL 1998 Laryngoscope CT 4 1 3 9 57%(21-94%) 90%(71-100%) 10
Takes RP 1998 Int J Radiat Oncol Biol Phys CT 14 3 12 35 54%(35-73%) 92%(84-100%) 11
Akoglu E 2005 J Otolaryngol CT 2 1 1 10 67%(13-100%) 91%(74-100%) 10
Wilson GR 1994 Br J Plast Surg MRI 11 14 0 13 100% 48%(29-67%) 11
Braams JW 1995 J Nucl Med MRI 3 2 2 5 60%(17-100%) 71%(38-100%) 7
Maremonti P 1997 J Craniomaxillofac Surg MRI 4 4 8 8 33%(7-60%) 67%(40-93%) 7
Yucel T 1997 Acta Radiol MRI 4 1 1 12 80%(45%-100%) 92%(78-100%) 10
Akoglu E 2005 J Otolaryngol MRI 2 1 1 10 67%(13-100%) 91%(74-100%) 10
Thomsen JB 2005 Acta Radiol MRI 5 4 9 52 36%(11-61%) 93%(86-100%) 7
Braams JW 1995 J Nucl Med PET 5 2 0 5 100% 71%(38-100%) 7
Myers LL 1998 J Otolaryngol PET 7 0 0 4 100% 100% 10
Myers LL 1998 Laryngoscope PET 7 0 2 15 78%(51-100%) 100% 10
Kau RJ 2002 Arch Otolaryngol Head Neck Surg PET 1 1 4 6 20%(0-55%) 86%(60-100%) 13
Brouwer J 2004 Eur Arch Otorhinolaryngol PET 2 1 1 11 67%(13-100%) 92%(76-100%) 9
Akoglu E 2005 J Otolaryngol PET 2 1 1 10 67%(13-100%) 91%(74-100%) 10
Schoder H 2006 J Nucl Med PET 6 4 3 23 67%(36-98%) 85%(72-99%) 10
Wensing BM 2006 Laryngoscope PET 3 4 5 16 38%(4-71%) 80%(63-98%) 11
Iyer NG 2010 Head Neck PET 15 4 14 113 52%(34-70%) 97%(93%-100%) 12
Liao CT 2010 J Nucl Med PET 26 66 33 143 55%(31-57%) 68%(62-75%) 13
Richard C 2010 Arch Otolaryngol Head Neck Surg PET 7 5 1 8 88%(65-100%) 62%(35-88%) 11
van den Brekel MW 1993 Eur Arch Otorhinolaryngol US 21 13 15 39 58%(42-74%) 75%(63-87%) 9
Maremonti P 1997 J Craniomaxillofac Surg US 8 1 4 11 67%(40-93%) 92%(76-100%) 7
Righi PD 1997 Head Neck US 6 5 4 18 60%(30-90%) 78%(61-95%) 7
Byers RM 1998 Head Neck US 3 4 8 10 27%(1-54%) 71%(48-95%) 5
Takes RP 1998 Int J Radiat Oncol Biol Phys US 18 11 8 27 69%(52-87%) 71%(57-86%) 11
Hodder SC 2000 Br J Oral Maxillofac Surg US 9 4 3 17 75%(51-100%) 81%(64-98%) 7
Akoglu E 2005 J Otolaryngol US 3 4 0 7 100% 64%(35-92%) 10
Thomsen JB 2005 Acta Radiol US 13 10 2 55 87%(70-100%) 85%(76-93%) 7
TP: true positive; FP: false positive; FN: false negative; FP: false positive.
QUADAS: Quality Assessment of Diagnostic Accuracy Studies.
Sensitivities and specificities with 95% confidence interval (CI) values were reported for individual studies.
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93% (87%~ 97%), 81% (64 ~ 91%), 87% (77 ~ 93%) and
78% (71~ 83%) for CT, MRI, PET and US, respectively.
There was no difference in QUADAS scores between the
studied modalities (p> 0.05).
Based on Bayesian theory and collected data with dif-
ferent pre-examination probabilities, the post examin-
ation positive and negative neck nodal probabilities were
simulated (Table 3 and Figure 3). With pre-examination
nodal metastasis set at 10%, 20% and 30%, the post-exam
positive nodal metastasis probabilities were 47%, 66%
and 77% for CT; 27%, 46% and 59% for MRI; 36%, 56%and 69% for PET; and 25%, 42% and 56% for US, re-
spectively. The negative nodal metastasis probabilities
were 95%, 89% and 82% for CT; 95%, 90% and 84% for
MRI; 96%, 91% and 86% for PET; and 95%, 90% and 84%
for US, respectively.
Discussions
In the development of treatment paradigms for cN0
neck, it is important to be aware that most patients with
a cN0 neck presented no cancer cells in the cervical
lymph nodes and that over-treating the neck should
be avoided.
Table 2 The pooled estimates of different imaging




















































*Yes: 1; No/unclear: 0.
LR+: likelihood ratio positive; LR-: likelihood ratio negative.
Table 3 The positive and negative predictive value of
nodal metastasis following imaging exams among














CT 10% 47% 95%
20% 66% 89%
30% 77% 82%
MRI 10% 27% 95%
20% 46% 90%
30% 59% 84%
PET 10% 36% 96%
20% 56% 91%
30% 69% 86%
US 10% 25% 95%
20% 42% 90%
30% 56% 84%
*: Possibility of neck nodal metastasis following a “positive” imaging result.
&: Possibility of “absent” neck nodal metastasis following a “negative” imaging
result.
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diagnostic tests can answer some clinically relevant ques-
tions, highlight important gaps in the evidence and aid
in the design of further studies. Our results are the first
to use meta-analytic data in neck metastasis rate esti-
mation on different pre-test probabilities among differ-
ent diagnostic imaging techniques. Because most
individual studies have a limited number of cases,
meta-analysis uses more data and provides more reli-
able results.
The optimal method for managing cN0 neck in SCC of
the head and neck remains controversial. In 1994, Weiss
et al. [3] recommended with decision analysis that when
the probability of occult cervical metastases is more than
20% (with a positive predictive rate above 20%), the neck
should be electively treated. Based on Bayesian theory,
the predictive probability of neck nodal metastasis givenFigure 2 The positive predictive value generated based on
Bayesian theory and the collected data.that a test is negative or positive depends on the pre-test
probability (baseline possibility), and the sensitivity and
specificity of the test. According to our results, if the
pretest prevalence (baseline possibility) of clinical occult
neck metastases was set at 30%, the post-test negativeFigure 3 The performance of different imaging modalities
shown with summary receiver operating characteristic curves.
The pooled estimates for sensitivity were 52%, 65%, 66% and 66%,
on a per-neck basis for CT, MRI, PET and US. The pooled estimates
for specificity were 93%, 81%, 87%, and 78% for CT, MRI, PET and US,
respectively.
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results increased to 82%, 84%, 86% and 84%, respectively
(with a positive neck lymph node metastasis rate below
20%), meaning a “watchful waiting policy” is possibly jus-
tified in these cases. In a recent report [8], the threshold
was estimated even higher (44.4%) for oral tongue can-
cer. The occult cervical lymph node metastasis rate has
been estimated at 25%~35%, except for the glottic lar-
ynx, by palpation [9]. Therefore, a “watchful waiting pol-
icy” is feasible for some low pre-test occult metastases in
cN0 neck patients, such as clinically T1~ 2N0M0 lip
cancer patients. However, some clinically T4N0 tongue
or tongue base cancers may have pre-test probability
>60%. Even with a negative imaging result, the post-test
probability is still approximately 20% (Figure 2), and
elected neck dissection is still necessary for these
patients. In patients with positive imaging results, even
with a very low pretest possibility set at 10%, the positive
nodal metastasis probabilities were all above 20% (47%,
27%, 36% and 25% for CT, MRI, PET and US, respect-
ively). Elective neck dissection should be performed for
all patients with positive pre-op diagnostic results.
According to our results, the pooled estimates for sen-
sitivity were 52% (95% confidence interval [CI],
39%~65%), 65% (34~ 87%), 66% (47~ 80%) and 66%
(54~ 77%) on a per-neck basis for CT, MRI, PET and
US, respectively. The pooled estimates for specificity
were 93% (87%~97%), 81% (64~ 91%), 87% (77 ~ 93%)
and 78% (71 ~ 83%) for CT, MRI, PET and US, respect-
ively. Our results are similar to a previous meta-analysis
[5], which compared PET to other traditional imaging
modalities (including CT, MRI and US-guided fine-
needle aspiration). This previous study concluded that
PET was not superior to other imaging modalities in a
cN0 neck work-up. However, the study was focused on
all nodal statuses and subgroup analysis for N0 patients
combined CT, MRI and US-guided fine-needle aspiration
(US-FNA) in the same group.
PET exam is the more expensive imaging option for
nodal surveillance; however, it did not provide better
sensitivity and specificity. Therefore, it should not be
routinely used in neck nodal status work-ups. In our
opinion, CT or MRI is preferred for cN0 neck pre-op
evaluation because CT and MRI had similar diagnostic
sensitivities to PET and US. Furthermore, CT and MRI
can evaluate the status of primary tumor at the same
time. The US is an inexpensive and convenient tool to
monitor nodal status and can be used with real-time
guided fine-needle aspiration. However, the primary
tumor lesion and some deep-seated lymph nodes, such
as retropharyngeal nodes, cannot be assessed [10].
The alignment of the results between preoperative im-
aging and histologic specimen after neck dissection
should be taken into consideration. According toprevious reported literatures [11,12], the rate of regional
recurrence in pN0 patients varying from 3% to 10%. Ap-
plying only the histopathological results as reference
standard, one could underestimate the real occult metas-
tasis rate. Therefore, we included studies using either
pathological examinations, or clinical follow-up results,
or both as references. Besides, the criteria for positive
results in pre-operative diagnostic imaging were not uni-
form in different institutions, and may be operator-
dependent. These variations all leaded to heterogeneity
in this meta-analysis, and this was the reason to adapt a
random effect model for data pooling.
During this review, we found that US-FNA had a very
high specificity; if the US-FNA cytology had a positive
result, almost all of the histology specimen results also
proved positive [1,13-15]. Therefore, in our opinion, US
is preferred for neck status follow-up in “watchful wait-
ing” patients, and US-FNA can be performed if nodal
metastasis is suspected.
In our review, we did not include US-FNA because
US-FNA cytology examination required a cytologist’s as-
sistance and was used after US examination. However, it
must be noted that US-FNA had 100% specificity be-
cause there were no false-positive cases. Therefore, we
did not believe that the comparison of sensitivity, specifi-
city and summary ROC curves were justified between
US-FNA and other imaging modalities because the lack
of false-positive cases spuriously inflates the value of the
area under the ROC curve.
In our review and subsequent meta-analysis, we found
modern imaging modalities had fair diagnostic perform-
ance in cN0 neck patients. For positive imaging results,
elective neck dissection is indicated; for some select low-
risk patients with pre-test probability below 30% of nodal
metastasis, a “watchful waiting policy” may be an accept-
able alternative to neck dissection if strict adherence to a
cancer surveillance protocol is followed.
Conclusions
Modern imaging modalities offer similar diagnostic ac-
curacy to define and diagnose cN0 neck. Minimizing
morbidity and avoiding elective neck dissection is ac-
ceptable in some select cases.
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